🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 18 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/11/2009 | 34,50 | 34,67 | 34,23 | 34,55 | -0,22% | 1,27% | 19.246.834 |
| 27/11/2009 | 34,33 | 34,87 | 33,99 | 34,63 | -0,77% | 2,56% | 9.402.551 |
| 25/11/2009 | 34,63 | 34,99 | 34,31 | 34,90 | +0,97% | 1,96% | 11.693.374 |
| 24/11/2009 | 34,62 | 35,14 | 34,22 | 34,56 | -0,55% | 2,67% | 22.260.673 |
| 23/11/2009 | 35,07 | 35,27 | 34,53 | 34,75 | -0,11% | 2,10% | 23.842.629 |
| 20/11/2009 | 33,83 | 34,99 | 33,71 | 34,79 | +3,20% | 3,78% | 38.112.721 |
| 19/11/2009 | 33,48 | 34,08 | 33,17 | 33,71 | +0,54% | 2,74% | 25.142.358 |
| 18/11/2009 | 32,70 | 33,78 | 32,52 | 33,53 | +2,48% | 3,85% | 29.544.482 |
| 17/11/2009 | 32,25 | 32,73 | 31,82 | 32,72 | +1,42% | 2,81% | 17.354.985 |
| 16/11/2009 | 32,42 | 32,78 | 31,98 | 32,26 | +2,15% | 2,44% | 26.302.180 |
| 13/11/2009 | 31,77 | 31,97 | 31,49 | 31,58 | +0,36% | 1,50% | 15.211.930 |
| 12/11/2009 | 31,53 | 31,94 | 31,36 | 31,47 | -0,72% | 1,85% | 14.775.542 |
| 11/11/2009 | 32,19 | 32,20 | 31,60 | 31,70 | -1,16% | 1,87% | 18.316.210 |
| 10/11/2009 | 31,98 | 32,19 | 31,80 | 32,07 | +0,54% | 1,22% | 16.626.520 |
| 09/11/2009 | 31,37 | 31,96 | 31,20 | 31,90 | +2,58% | 2,40% | 30.584.098 |
| 06/11/2009 | 31,12 | 31,44 | 30,74 | 31,10 | -0,37% | 2,24% | 20.797.141 |
| 05/11/2009 | 31,00 | 31,90 | 31,00 | 31,21 | +0,21% | 2,89% | 23.830.786 |
| 04/11/2009 | 29,90 | 31,35 | 29,82 | 31,15 | +6,42% | 5,11% | 37.948.290 |
| 03/11/2009 | 29,67 | 29,85 | 28,90 | 29,27 | -1,89% | 3,18% | 71.181.522 |
| 02/11/2009 | 29,69 | 30,06 | 29,54 | 29,83 | +1,07% | 1,74% | 22.417.244 |
| 30/10/2009 | 29,74 | 30,32 | 29,42 | 29,51 | -1,21% | 3,05% | 42.406.377 |
| 29/10/2009 | 30,56 | 30,56 | 29,48 | 29,88 | -2,31% | 3,53% | 42.898.518 |
| 28/10/2009 | 31,10 | 31,20 | 30,53 | 30,58 | -1,17% | 2,15% | 15.802.268 |
| 27/10/2009 | 31,10 | 31,39 | 30,70 | 30,94 | +1,28% | 2,24% | 19.670.541 |
| 26/10/2009 | 31,01 | 31,53 | 30,41 | 30,55 | -1,26% | 3,60% | 19.226.084 |
| 23/10/2009 | 31,26 | 31,44 | 30,71 | 30,94 | -1,34% | 2,35% | 17.948.153 |
| 22/10/2009 | 30,91 | 31,40 | 29,83 | 31,36 | +0,58% | 5,09% | 25.450.575 |
| 21/10/2009 | 32,20 | 32,25 | 31,12 | 31,18 | -3,08% | 3,53% | 25.395.241 |
| 20/10/2009 | 32,36 | 32,61 | 32,09 | 32,18 | -0,03% | 1,62% | 24.308.989 |
| 19/10/2009 | 31,59 | 32,28 | 31,59 | 32,19 | +1,57% | 2,17% | 29.333.310 |